The efficacy and safety of abatacept or infliximab in ra patients with an inadequate response to MTX: Results from a 1-year double-blind, randomized, placebo-controlled trial

Category Primary study
JournalJournal of Rheumatology
Year 2007
This article has no abstract
Epistemonikos ID: d2944a0711f380f22f358e2d155de57129fdbc57
First added on: Feb 03, 2013